Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Deletion Analysis of the p16/CDKN2 Gene in Head and Neck Squamous Cell Carcinoma Using Quantitative Polymerase Chain Reaction Method

Deletion Analysis of the p16/CDKN2 Gene in Head and Neck Squamous Cell Carcinoma Using... Abstract Background: Recently, the p16/CDKN2/MTS1 gene in the 9p21-22 region has been offered as a candidate tumor suppressor gene. We examined the frequency of hemizygous and homozygous deletions of p16/CDKN2 in head and neck squamous cell carcinoma (HNSCC) using a quantitative polymerase chain reaction (PCR) method. Design: Twenty-one HNSCC and 12 corresponding normal DNA samples were examined for deletion of p16/CDKN2 using PCR amplification and fluorescent quantification of DNA. All tumor and normal DNA samples were also amplified with fluorescein-labeled primers for a control DNA marker on chromosome 8p (D8S265). The ratios of the observed fluorescence of the p16/CDKN2 and 8p PCR products were compared. Setting and participants: Patients with HNSCC scheduled to undergo surgical resection of their tumors were recruited. After the specimen was removed, a portion of the tissue was snap frozen for further DNA extraction. Results: Eight tumors (38%) had p16/CDKN2-D8S265 ratios of greater than 0.75; 8 tumors (38%), from 0.25 to 0.75; and 5 tumors (24%), of less than 0.25, the average ratio in this last group being 0.06. Conclusions: These ratios suggest a higher rate of homozygous deletion than previously reported and significant probable hemizygous deletion of the p16/CDKN2 gene in HNSCC.Arch Otolaryngol Head Neck Surg. 1997;123:863-867 References 1. Parkin D, Laara F, Muir C. Cancer incidence in five continents: comparability and quality of data . Int J Cancer . 1988;41:184-197.Crossref 2. Kamb A. Cell cycle regulators and cancer . Trends Genet . 1995;11:136-140.Crossref 3. Van der Riet P. Nawroz H, Hruban RH, et al. Frequent loss of chromosome 9p21 -22 early in head and neck cancer progression . Cancer Res . 1994;54:1156-1158. 4. Serrano M, Hannon GJ, Beach D, et al. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4 . Nature . 1993;366:704-707.Crossref 5. Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types . Science . 1994;264:436-439.Crossref 6. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletions of cyclindependent kinase-4 inhibitor gene in multiple human cancers . Nature . 1994;368: 753-756.Crossref 7. Mori T, Miura K, Aoki T, Mishihira T, Mori S, Nakamura Y. Frequent somatic mutations of the MTS1/CDK4I gene in esophageal cancer . Cancer Res . 1994;54: 3396-3397. 8. Zhang SY, Klein-Szanto AJ, Sauter ER, Shafarenko M, Mitsunaga S, Nobori T. Higher frequency of alterations in the p16/CDKN1 gene squamous carcinoma lines than in primary tumors of the head and neck . Cancer Res . 1994;54:5050-5053. 9. Srivatsan E, Benedict W, Stanbridge E. Implications of chromosome 11 in suppression of neoplastic expression in human cell hybrids . Cancer Res . 1986;46: 6174-6179. 10. Weissenbach J, Gyapay G, Dib C, et al. A second generation linkage map . Nature . 1992;359:794-801.Crossref 11. Van Dyke DL, Worsham MJ, Benninger MS, Krause CJ, Baker SR, Wolf GT. Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region . Genes Chromosomes Cancer . 1994;9:192-206.Crossref 12. Nawroz H, van der Riet P, Hruban RH, Koch W, Ruppert JM, Sidransky D. Allelotype of head and neck squamous carcinoma . Cancer Res . 1994;54:1152-1155. 13. Reed AL, Califano J. Cairns P, et al. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma . Cancer Res . 1996; 56:3630-3633. 14. Cairns P, Mao L, Merlo A, et al. Rates of p16 (MTS1) mutations in primary tumors with 9p loss . Science . 194;265:415-417.Crossref http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Otolaryngology - Head & Neck Surgery American Medical Association

Deletion Analysis of the p16/CDKN2 Gene in Head and Neck Squamous Cell Carcinoma Using Quantitative Polymerase Chain Reaction Method

Download PDF
5 pages
Read Article

Loading next page...
 
/lp/american-medical-association/deletion-analysis-of-the-p16-cdkn2-gene-in-head-and-neck-squamous-cell-EGzwd8sdrc
Publisher
American Medical Association
Copyright
Copyright © 1997 American Medical Association. All Rights Reserved.
ISSN
0886-4470
eISSN
1538-361X
DOI
10.1001/archotol.1997.01900080097012
Publisher site
See Article on Publisher Site

Abstract

Abstract Background: Recently, the p16/CDKN2/MTS1 gene in the 9p21-22 region has been offered as a candidate tumor suppressor gene. We examined the frequency of hemizygous and homozygous deletions of p16/CDKN2 in head and neck squamous cell carcinoma (HNSCC) using a quantitative polymerase chain reaction (PCR) method. Design: Twenty-one HNSCC and 12 corresponding normal DNA samples were examined for deletion of p16/CDKN2 using PCR amplification and fluorescent quantification of DNA. All tumor and normal DNA samples were also amplified with fluorescein-labeled primers for a control DNA marker on chromosome 8p (D8S265). The ratios of the observed fluorescence of the p16/CDKN2 and 8p PCR products were compared. Setting and participants: Patients with HNSCC scheduled to undergo surgical resection of their tumors were recruited. After the specimen was removed, a portion of the tissue was snap frozen for further DNA extraction. Results: Eight tumors (38%) had p16/CDKN2-D8S265 ratios of greater than 0.75; 8 tumors (38%), from 0.25 to 0.75; and 5 tumors (24%), of less than 0.25, the average ratio in this last group being 0.06. Conclusions: These ratios suggest a higher rate of homozygous deletion than previously reported and significant probable hemizygous deletion of the p16/CDKN2 gene in HNSCC.Arch Otolaryngol Head Neck Surg. 1997;123:863-867 References 1. Parkin D, Laara F, Muir C. Cancer incidence in five continents: comparability and quality of data . Int J Cancer . 1988;41:184-197.Crossref 2. Kamb A. Cell cycle regulators and cancer . Trends Genet . 1995;11:136-140.Crossref 3. Van der Riet P. Nawroz H, Hruban RH, et al. Frequent loss of chromosome 9p21 -22 early in head and neck cancer progression . Cancer Res . 1994;54:1156-1158. 4. Serrano M, Hannon GJ, Beach D, et al. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4 . Nature . 1993;366:704-707.Crossref 5. Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types . Science . 1994;264:436-439.Crossref 6. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletions of cyclindependent kinase-4 inhibitor gene in multiple human cancers . Nature . 1994;368: 753-756.Crossref 7. Mori T, Miura K, Aoki T, Mishihira T, Mori S, Nakamura Y. Frequent somatic mutations of the MTS1/CDK4I gene in esophageal cancer . Cancer Res . 1994;54: 3396-3397. 8. Zhang SY, Klein-Szanto AJ, Sauter ER, Shafarenko M, Mitsunaga S, Nobori T. Higher frequency of alterations in the p16/CDKN1 gene squamous carcinoma lines than in primary tumors of the head and neck . Cancer Res . 1994;54:5050-5053. 9. Srivatsan E, Benedict W, Stanbridge E. Implications of chromosome 11 in suppression of neoplastic expression in human cell hybrids . Cancer Res . 1986;46: 6174-6179. 10. Weissenbach J, Gyapay G, Dib C, et al. A second generation linkage map . Nature . 1992;359:794-801.Crossref 11. Van Dyke DL, Worsham MJ, Benninger MS, Krause CJ, Baker SR, Wolf GT. Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region . Genes Chromosomes Cancer . 1994;9:192-206.Crossref 12. Nawroz H, van der Riet P, Hruban RH, Koch W, Ruppert JM, Sidransky D. Allelotype of head and neck squamous carcinoma . Cancer Res . 1994;54:1152-1155. 13. Reed AL, Califano J. Cairns P, et al. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma . Cancer Res . 1996; 56:3630-3633. 14. Cairns P, Mao L, Merlo A, et al. Rates of p16 (MTS1) mutations in primary tumors with 9p loss . Science . 194;265:415-417.Crossref

Journal

Archives of Otolaryngology - Head & Neck Surgery – American Medical Association

Published: Aug 1, 1997

References

  • Cancer incidence in five continents: comparability and quality of data
    Parkin D, Laara F, Muir C
  • Cell cycle regulators and cancer
    Kamb A
  • Frequent loss of chromosome 9p21 -22 early in head and neck cancer progression
    Van der Riet P. Nawroz H, Hruban RH, et al
  • A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4
    Serrano M, Hannon GJ, Beach D, et al
  • A cell cycle regulator potentially involved in genesis of many tumor types
    Kamb A, Gruis NA, Weaver-Feldhaus J, et al
  • Deletions of cyclindependent kinase-4 inhibitor gene in multiple human cancers
    Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA
  • Frequent somatic mutations of the MTS1/CDK4I gene in esophageal cancer
    Mori T, Miura K, Aoki T, Mishihira T, Mori S, Nakamura Y
  • Higher frequency of alterations in the p16/CDKN1 gene squamous carcinoma lines than in primary tumors of the head and neck
    Zhang SY, Klein-Szanto AJ, Sauter ER, Shafarenko M, Mitsunaga S, Nobori T
  • Implications of chromosome 11 in suppression of neoplastic expression in human cell hybrids
    Srivatsan E, Benedict W, Stanbridge E
  • A second generation linkage map
    Weissenbach J, Gyapay G, Dib C, et al
  • Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region
    Van Dyke DL, Worsham MJ, Benninger MS, Krause CJ, Baker SR, Wolf GT
  • Allelotype of head and neck squamous carcinoma
    Nawroz H, van der Riet P, Hruban RH, Koch W, Ruppert JM, Sidransky D
  • High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma
    Reed AL, Califano J. Cairns P, et al
  • Rates of p16 (MTS1) mutations in primary tumors with 9p loss
    Cairns P, Mao L, Merlo A, et al

You’re reading a free preview. Subscribe to read the entire article.

Try 2 weeks free now

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

or browse the journals available

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$499/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

Sign up
for free
Start 14 day
Free Trial